| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $999.4M | +11.0% |
| Cost of Revenue | $218.9M | +9.7% |
| Gross Profit | $780.5M | +11.4% |
| R&D Expense | $223.7M | +23.1% |
| SG&A Expense | $145.9M | +17.5% |
| Operating Income | -$9.2M | -33.7% |
| Income Tax | $13.2M | -24.3% |
| Net Income | -$36.1M | +0.5% |
| EPS (Basic) | -$0.30 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $187.8M | -42.9% |
| Short-term Investments | $214.4M | -13.7% |
| Accounts Receivable | $279.1M | +7.9% |
| Current Assets | $773.6M | -17.8% |
| Total Assets | $1.75B | +0.3% |
| Current Liabilities | $812.9M | +10.1% |
| Total Liabilities | $1.42B | +5.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $266.8M | +22.7% |
| Capital Expenditures | $12.1M | +185.0% |
| Investing Cash Flow | -$174.6M | -321.4% |
| Financing Cash Flow | -$234.1M | -194.8% |
| Free Cash Flow | $254.6M | +19.4% |
| +3.2% |
| EPS (Diluted) | -$0.30 | +3.2% |
| Stockholders' Equity |
| $326.4M |
| -18.4% |